Why Responsible Distribution Matters
Speech generating devices are not off-the-shelf consumer products. They are specialized medical technologies designed to support individuals with significant communication impairments.
Tobii Dynavox believes these systems should be distributed through clinically appropriate processes that include evaluation, configuration, training, implementation, and long-term support. Responsible distribution helps ensure that patients receive communication solutions that are appropriate for their needs and supported.
According to the complaint, AbleNet allegedly enables the use of TD Snap® software on its hardware without authorization by directing patients or clinicians to independently acquire and install the software using Apple gift cards and related instructions.
The lawsuit alleges that this model bypasses the integrated approach traditionally associated with fully supported speech generating devices. Tobii Dynavox believes that separating the software, hardware, and support structure can create confusion regarding accountability, patient support responsibilities, and long-term maintenance.
Tobii Dynavox has invested significantly in clinical infrastructure, software development, support systems, localization, training programs, and ongoing innovation to ensure that patients and clinicians receive reliable, end-to-end communication solutions. The company believes responsible distribution is essential to maintaining quality, accountability, and long-term success for the individuals who rely on these technologies every day.
